EE200300031A - Klimakteersete häirete ravimeetod naistel menopausi ajal või järel - Google Patents

Klimakteersete häirete ravimeetod naistel menopausi ajal või järel

Info

Publication number: EE200300031A
Authority: EE; Estonia
Prior art keywords: menopause; women during; treating climacteric; climacteric disorders; atrophy
Prior art date: 2000-07-21

Application number

EEP200300031A

Other languages

English (en)

Inventor

Halonen Kaija

Kangas Lauri

W. Degregorio Michael

Original Assignee

Hormos Medical Corporation

Tess Diagnostics And Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2001-05-02

Publication date

2004-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24504996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300031(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-02 Application filed by Hormos Medical Corporation, Tess Diagnostics And Pharmaceuticals, Inc. filed Critical Hormos Medical Corporation

2004-10-15 Publication of EE200300031A publication Critical patent/EE200300031A/et

2010-10-15 Publication of EE05344B1 publication Critical patent/EE05344B1/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EEP200300031A 2000-07-21 2001-05-02 Ühendi (deaminohüdroksü)toremifeeni kasutamine tupekuivuse v?i seksuaaldüsfunktsiooni ravis menopausi ajal v?i järel EE05344B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/625,199 US6245819B1 (en)	2000-07-21	2000-07-21	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
PCT/FI2001/000414 WO2002007718A1 (en)	2000-07-21	2001-05-02	Method for the treatment of climacteric disorders in women during or after the menopause

Publications (2)

Publication Number	Publication Date
EE200300031A true EE200300031A (et)	2004-10-15
EE05344B1 EE05344B1 (et)	2010-10-15

Family

ID=24504996

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300031A EE05344B1 (et)	2000-07-21	2001-05-02	Ühendi (deaminohüdroksü)toremifeeni kasutamine tupekuivuse v?i seksuaaldüsfunktsiooni ravis menopausi ajal v?i järel

Country Status (30)

Country	Link
US (5)	US6245819B1 (et)
EP (1)	EP1305014B1 (et)
JP (2)	JP5575351B2 (et)
KR (1)	KR100880564B1 (et)
CN (1)	CN1287775C (et)
AT (1)	ATE300289T1 (et)
AU (2)	AU2001258449B2 (et)
BG (1)	BG65943B1 (et)
BR (1)	BR0112659A (et)
CA (1)	CA2416480C (et)
CY (1)	CY1105370T1 (et)
CZ (1)	CZ299439B6 (et)
DE (1)	DE60112301T2 (et)
DK (1)	DK1305014T3 (et)
EE (1)	EE05344B1 (et)
ES (1)	ES2241819T3 (et)
HR (1)	HRP20030024A2 (et)
HU (1)	HU229361B1 (et)
IL (1)	IL153823A (et)
MX (1)	MXPA03000378A (et)
NO (1)	NO329954B1 (et)
NZ (1)	NZ524181A (et)
PL (1)	PL202654B1 (et)
PT (1)	PT1305014E (et)
RU (1)	RU2268035C2 (et)
SI (1)	SI1305014T1 (et)
SK (1)	SK287096B6 (et)
UA (1)	UA74386C2 (et)
WO (1)	WO2002007718A1 (et)
ZA (1)	ZA200300342B (et)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL120266A (en) *	1996-02-28	2005-05-17	Pfizer	Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
US20020013327A1 (en) *	2000-04-18	2002-01-31	Lee Andrew G.	Compositions and methods for treating female sexual dysfunction
WO2001085013A2 (en)	2000-05-09	2001-11-15	Nitromed, Inc.	Infrared thermography and methods of use
US6245819B1 (en) *	2000-07-21	2001-06-12	Hormos Medical Oy, Ltd.	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
CN101406464A (zh) *	2002-06-06	2009-04-15	霍尔莫斯医疗有限公司	抑制女性萎缩或治疗或预防与女性萎缩相关的症状的方法
JP2006515276A (ja) *	2002-10-22	2006-05-25	オスコテック株式会社	骨粗鬆症の予防及び治療効果を有するフラン誘導体並びにこれを含む薬学的組成物
US20040248989A1 (en) *	2003-06-05	2004-12-09	Risto Santti	Method for the treatment or prevention of lower urinary tract symptoms
US8236861B2 (en) *	2004-02-13	2012-08-07	Hormos Medical Corporation	Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) *	2004-02-23	2014-02-04	Hormos Medical Corporation	Solid formulations of ospemifene
US20050187302A1 (en) *	2004-02-23	2005-08-25	Hormos Medical Corporation	Method for treatment or prevention of osteoporosis in individuals with high bone turnover
US8758821B2 (en)	2004-05-04	2014-06-24	Hormos Medical Ltd.	Oral formulations of ospemifene
KR101278934B1 (ko) *	2004-05-04	2013-06-26	호르모스 메디칼 리미티드	오스페미펜의 신규 경구 제제
KR100734942B1 (ko)	2007-01-02	2007-07-03	김재현	여성 갱년기 증후군에 유효한 건강기능식품 조성물
WO2008099060A2 (en) *	2007-02-14	2008-08-21	Hormos Medical Ltd	Methods for the preparation of fispemifene from ospemifene
BRPI0807675B1 (pt)	2007-02-14	2021-05-18	Hormos Medical Ltd.	método para a preparação de um composto derivado de trifenilbuteno
US20080293683A1 (en) *	2007-05-24	2008-11-27	University Of Kansas Medical Center	Hormone Replacement Therapy
RU2535112C2 (ru) *	2012-09-19	2014-12-10	Государственное бюджетное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия министерства здравоохранения и социального развития"	Способ лечения климактерических и урогенитальных расстройств у женщин в постменопаузе на фоне гипотириоза
US9321712B2 (en)	2012-10-19	2016-04-26	Fermion Oy	Process for the preparation of ospemifene
JP6453482B2 (ja)	2015-03-10	2019-01-16	シオノギインク．	固体分散体
WO2016149675A1 (en)	2015-03-19	2016-09-22	Epstein Wendy Anne	Compounds and forms of treatment for female sexual disorders
RU2636619C1 (ru) *	2017-02-20	2017-11-24	Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации	Способ лечения вагинальной атрофии у женщин в постменопаузе с учетом состояния эпителия и микробиоценоза влагалища

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5352699A (en) *	1992-04-30	1994-10-04	University Of Massachusetts Medical Center	Use of retinioc acid to treat vaginal atrophy
US5461064A (en) *	1993-12-21	1995-10-24	Eli Lilly And Company	Methods of inhibiting atrophy of the skin and vagina
GB9418067D0 (en)	1994-09-07	1994-10-26	Orion Yhtymae Oy	Triphenylethylenes for the prevention and treatment of osteoporosis
US5747059A (en) *	1996-01-11	1998-05-05	Novo Nordisk A/S	Atrophy of skin/mucous membrane
GB9604577D0 (en) *	1996-03-04	1996-05-01	Orion Yhtymae Oy	Serum cholesterol lowering agent
CO5271697A1 (es) *	2000-01-12	2003-04-30	Pfizer Prod Inc	Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona
SK9592002A3 (en)	2000-01-28	2003-12-02	Endorech Inc	A method for reduction or elimination of the incidence of menopausal symptoms, method of treatment or decreasing the risk of an acquiring disease, a pharmaceutical composition and a kit
US20010034340A1 (en)	2000-03-20	2001-10-25	American Home Products Corporation	Hormone replacement therapy
US6245819B1 (en) *	2000-07-21	2001-06-12	Hormos Medical Oy, Ltd.	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

2000
- 2000-07-21 US US09/625,199 patent/US6245819B1/en not_active Expired - Lifetime
2001
- 2001-02-05 UA UA2003021522A patent/UA74386C2/uk unknown
- 2001-05-02 HR HR20030024A patent/HRP20030024A2/xx not_active Application Discontinuation
- 2001-05-02 AU AU2001258449A patent/AU2001258449B2/en not_active Expired
- 2001-05-02 MX MXPA03000378A patent/MXPA03000378A/es active IP Right Grant
- 2001-05-02 RU RU2003105159/14A patent/RU2268035C2/ru active
- 2001-05-02 DE DE60112301T patent/DE60112301T2/de not_active Expired - Lifetime
- 2001-05-02 DK DK01931746T patent/DK1305014T3/da active
- 2001-05-02 WO PCT/FI2001/000414 patent/WO2002007718A1/en not_active Ceased
- 2001-05-02 CA CA002416480A patent/CA2416480C/en not_active Expired - Lifetime
- 2001-05-02 KR KR1020027015576A patent/KR100880564B1/ko not_active Expired - Lifetime
- 2001-05-02 NZ NZ524181A patent/NZ524181A/en not_active IP Right Cessation
- 2001-05-02 HU HU0301791A patent/HU229361B1/hu unknown
- 2001-05-02 SK SK1607-2002A patent/SK287096B6/sk not_active IP Right Cessation
- 2001-05-02 EP EP01931746A patent/EP1305014B1/en not_active Expired - Lifetime
- 2001-05-02 CN CNB018130194A patent/CN1287775C/zh not_active Expired - Lifetime
- 2001-05-02 IL IL153823A patent/IL153823A/en active IP Right Grant
- 2001-05-02 BR BR0112659-8A patent/BR0112659A/pt not_active Application Discontinuation
- 2001-05-02 SI SI200130410T patent/SI1305014T1/sl unknown
- 2001-05-02 ES ES01931746T patent/ES2241819T3/es not_active Expired - Lifetime
- 2001-05-02 AT AT01931746T patent/ATE300289T1/de active
- 2001-05-02 CZ CZ20030026A patent/CZ299439B6/cs not_active IP Right Cessation
- 2001-05-02 JP JP2002513454A patent/JP5575351B2/ja not_active Expired - Lifetime
- 2001-05-02 EE EEP200300031A patent/EE05344B1/et unknown
- 2001-05-02 PT PT01931746T patent/PT1305014E/pt unknown
- 2001-05-02 AU AU5844901A patent/AU5844901A/xx active Pending
- 2001-05-02 PL PL359506A patent/PL202654B1/pl unknown
2002
- 2002-06-06 US US10/162,708 patent/US6984665B2/en not_active Expired - Lifetime
2003
- 2003-01-13 ZA ZA200300342A patent/ZA200300342B/en unknown
- 2003-01-17 BG BG107472A patent/BG65943B1/bg unknown
- 2003-01-20 NO NO20030273A patent/NO329954B1/no not_active IP Right Cessation
2005
- 2005-08-11 US US11/201,098 patent/US20050272825A1/en not_active Abandoned
- 2005-10-26 CY CY20051101313T patent/CY1105370T1/el unknown
2010
- 2010-07-15 US US12/837,292 patent/US9566252B2/en not_active Expired - Fee Related
2012
- 2012-10-25 JP JP2012235543A patent/JP5629746B2/ja not_active Expired - Lifetime
2014
- 2014-01-24 US US14/163,757 patent/US20140142195A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CY1105370T1 (el)	2010-04-28
JP5575351B2 (ja)	2014-08-20
BR0112659A (pt)	2003-06-24
ES2241819T3 (es)	2005-11-01
DE60112301D1 (de)	2005-09-01
RU2268035C2 (ru)	2006-01-20
WO2002007718A8 (en)	2002-11-14
US20050272825A1 (en)	2005-12-08
ZA200300342B (en)	2004-02-13
KR100880564B1 (ko)	2009-01-30
US20100280131A1 (en)	2010-11-04
DE60112301T2 (de)	2006-05-24
EP1305014B1 (en)	2005-07-27
DK1305014T3 (da)	2005-08-22
AU2001258449B2 (en)	2004-07-29
CN1446085A (zh)	2003-10-01
CZ200326A3 (cs)	2003-05-14
JP5629746B2 (ja)	2014-11-26
NZ524181A (en)	2003-07-25
HUP0301791A2 (hu)	2003-12-29
WO2002007718A1 (en)	2002-01-31
AU5844901A (en)	2002-02-05
NO329954B1 (no)	2011-01-31
IL153823A (en)	2008-03-20
PL359506A1 (en)	2004-08-23
HU229361B1 (en)	2013-11-28
HK1056694A1 (en)	2004-02-27
MXPA03000378A (es)	2003-09-22
IL153823A0 (en)	2003-07-31
JP2013060445A (ja)	2013-04-04
JP2004504345A (ja)	2004-02-12
PL202654B1 (pl)	2009-07-31
US9566252B2 (en)	2017-02-14
SK287096B6 (sk)	2009-12-07
CA2416480C (en)	2009-12-08
KR20030048378A (ko)	2003-06-19
ATE300289T1 (de)	2005-08-15
BG107472A (bg)	2003-11-28
US6984665B2 (en)	2006-01-10
NO20030273D0 (no)	2003-01-20
CA2416480A1 (en)	2002-01-31
NO20030273L (no)	2003-01-20
SK16072002A3 (sk)	2003-06-03
CN1287775C (zh)	2006-12-06
HUP0301791A3 (en)	2008-01-28
HRP20030024A2 (en)	2006-12-31
CZ299439B6 (cs)	2008-07-30
UA74386C2 (uk)	2005-12-15
PT1305014E (pt)	2005-09-30
US20140142195A1 (en)	2014-05-22
EP1305014A1 (en)	2003-05-02
US20030036566A1 (en)	2003-02-20
US6245819B1 (en)	2001-06-12
SI1305014T1 (sl)	2005-12-31
BG65943B1 (bg)	2010-06-30
EE05344B1 (et)	2010-10-15

Publication	Publication Date	Title
EE200300031A (et)	2004-10-15	Klimakteersete häirete ravimeetod naistel menopausi ajal või järel
EA200201000A1 (ru)	2003-02-27	Гормон-заместительная терапия
RU2003105159A (ru)	2004-08-27	Способ лечения климактерических расстройств у женщин во время или после менопаузы
MEP54608A (en)	2011-05-10	Arylmethylamine derivatives for use as tryptase inhibitors
IL164528A (en)	2010-06-30	Method for inhibition of atrophy or for treatment or prevention of atrophy related symptoms in women
IL159241A0 (en)	2004-06-01	Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
ATE539749T1 (de)	2012-01-15	Dextromethorphan für die behandlung von akne
BR0309032A (pt)	2005-02-01	Método para tratar sintomas vasomotores, a menopausa, deficiências hormonais em um paciente, e para tratar um paciente que sofre de sintomas vasomotores
CL2021003303A1 (es)	2022-08-19	Tratamiento para sinucleinopatías.
DE60004996D1 (de)	2003-10-09	Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
IL136717A (en)	2007-05-15	Carboxylic acid substituted heterocycles as metalloproteinase inhibitors
SI1553938T1 (sl)	2007-06-30	Uporaba epotilonskih derivatov za zdravljenje hiperparatiroidizma

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231